ArticleFrontiers in oncology2024

Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer.

Chenglou Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.